Price T Rowe Associates Inc Pds Biotechnology Corp Call Options Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PDSB
# of Institutions
77Shares Held
7.53MCall Options Held
140KPut Options Held
318K-
Black Rock Inc. New York, NY1.87MShares$7.28 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.59MShares$6.19 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA654KShares$2.55 Million0.0% of portfolio
-
State Street Corp Boston, MA557KShares$2.17 Million0.0% of portfolio
-
Inspirion Wealth Advisors, LLC360KShares$1.4 Million0.16% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $111M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...